Brief: NeuroMetrix Names Jonathan Breck Harmel As National Director Of Sales For Prescription Neurotherapeutics Business
01/09/2022 14:08
Sept 1 (Reuters) - NeuroMetrix Inc NURO.O :
* NEUROMETRIX NAMES JONATHAN BRECK HARMEL AS NATIONAL
DIRECTOR OF
SALES FOR ITS EMERGING PRESCRIPTION NEUROTHERAPEUTICS BUSINESS
Source text for Eikon: ID:nGNX50nmRd
Further company coverage: NURO.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on NeuroMetrix
See all newsBrief: Neurometrix To Be Acquired By Electrocore
Brief: Neurometrix Reiterates Its Review Of Strategic Alternatives
Brief: NeuroMetrix Announces Steps Taken To Enhance Shareholder Value
Brief: Ephraim Fields Reports 9.3% Stake In Neurometrix, Inc. As Of Feb 23, 2024 - SEC Filing
Brief: RS Fund Reports 14.4% Stake In Neurometrix Inc As Of Feb 13